|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
PD-L1
(SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance
Eun Kyung Han, Ji Won Woo, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park
Cancer Res Treat.
2024;56(2):557-566. Published online December 12, 2023 DOI:
https://doi.org/10.4143/crt.2023.1025
Rare Cancer
Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center
Young Sok Ji, Se Hoon Park
Cancer Res Treat.
2021;53(3):874-880. Published online December 7, 2020 DOI:
https://doi.org/10.4143/crt.2020.1066
Web of Science 8
Crossref 7
A Radiosensitivity Gene Signature and
PD-L1
Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset
Bum-Sup Jang, In Ah Kim
Cancer Res Treat.
2020;52(2):530-542. Published online November 20, 2019 DOI:
https://doi.org/10.4143/crt.2019.440
Web of Science 14
Crossref 13
Apatinib Combined with Local Irradiation Leads to Systemic Tumor Control via Reversal of Immunosuppressive Tumor Microenvironment in Lung Cancer
Li-jun Liang, Chen-xi Hu, Yi-xuan Wen, Xiao-wei Geng, Ting Chen, Guo-qing Gu, Lei Wang, You-you Xia, Yong Liu, Jia-yan Fei, Jie Dong, Feng-hua Zhao, Yiliyar Ahongjiang, Kai-yuan Hui, Xiao-dong Jiang
Cancer Res Treat.
2020;52(2):406-418. Published online September 3, 2019 DOI:
https://doi.org/10.4143/crt.2019.296
Web of Science 4
Crossref 3
Therapeutic Co-targeting of WEE1 and ATM Downregulates
PD-L1
Expression in Pancreatic Cancer
Mei Hua Jin, Ah-Rong Nam, Ji Eun Park, Ju-Hee Bang, Yung-Jue Bang, Do-Youn Oh
Cancer Res Treat.
2020;52(1):149-166. Published online June 25, 2019 DOI:
https://doi.org/10.4143/crt.2019.183
Web of Science 30
Crossref 27
Effect of Platinum-Based Chemotherapy on
PD-L1
Expression on Tumor Cells in Non-small Cell Lung Cancer
Junghoon Shin, Jin-Haeng Chung, Se Hyun Kim, Kyu Sang Lee, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Jeong-Ok Lee, Jin-Won Kim, Yu-Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee
Cancer Res Treat.
2019;51(3):1086-1097. Published online November 5, 2018 DOI:
https://doi.org/10.4143/crt.2018.537
Web of Science 55
Crossref 51
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
Min Hwan Kim, Xianglan Zhang, Minkyu Jung, Inkyung Jung, Hyung Soon Park, Seung-Hoon Beom, Hyo Song Kim, Sun Young Rha, Hyunki Kim, Yoon Young Choi, Taeil Son, Hyoung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Hyun Cheol Chung
Cancer Res Treat.
2019;51(2):819-831. Published online September 27, 2018 DOI:
https://doi.org/10.4143/crt.2018.331
Web of Science 9
Crossref 8
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
Jieun Lee, Dong-Min Kim, Ahwon Lee
Cancer Res Treat.
2019;51(2):649-663. Published online July 31, 2018 DOI:
https://doi.org/10.4143/crt.2018.270
Web of Science 51
Crossref 42
Association of Immune-Related Adverse Events and the Efficacy of Anti-PD-(L)1 Monotherapy in Non-Small Cell Lung Cancer: Adjusting for Immortal-Time Bias
Ying Yu, Ning Chen, Sizhe Yu, Wanji Shen, Wanchen Zhai, Hui Li, Yun Fan
Received October 11, 2023 Accepted December 30, 2023 Published online January 2, 2024
DOI:
https://doi.org/10.4143/crt.2023.1118
[Accepted]
1
Journal Impact Factor 4.6
> Browse Articles > Search
